Status:

COMPLETED

Infrared Wraps Effect on Oxygenation of Diabetics Arm, Feet and Lower Leg

Lead Sponsor:

Yale University

Collaborating Sponsors:

CIRCUFIBER, Inc.

Conditions:

Diabetes

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

This study seeks to prove that wraps manufactured with infrared textile are capable of augmenting peripheral circulation in the lower legs, arm and feet of participants with Diabetes Mellitus. Infrare...

Detailed Description

Infrared energy is a type of electromagnetic energy that is invisible, and is further subdivided into three subsets based on wavelength. Far infrared (FIR or IR-C) is a subset of energy in the infrare...

Eligibility Criteria

Inclusion

  • Patient with Type 1 or Type 2 Diabetes Mellitus between the ages of 18 and 80 years old.

Exclusion

  • Chronic kidney disease treated by dialysis or those with a eGFR\<30 mL/min/1.73m2
  • Alcohol or any illicit substance abuse
  • Use of systemic corticosteroids within previous 3 months
  • Has ever received immunosuppressive agents
  • Has ever undergone radiation therapy
  • Has ever used cytotoxic agents
  • Pregnant, breast-feeding or attempting to become pregnant
  • History of known peripheral arterial disease or lower extremity amputation
  • Any neurologic disease or other condition preventing normal ambulation
  • History of significant trauma to the lower extremities, major orthopedic or neurological damage to the lower extremities
  • History of saphenous venous graft harvesting
  • Ankle-Brachial Index of 0.40 or lower
  • Any ulcer or open wound on the lower extremities
  • Inability to lie flat for up to 90 minutes at a time
  • Any symptoms within past 21 days of cough, fever, sore throat, chills, body aches, shortness of breath, loss of smell, loss of taste, fever at or greater than 100 degrees Fahrenheit
  • COVID positive nasal swab within past 21 days

Key Trial Info

Start Date :

May 26 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 12 2022

Estimated Enrollment :

39 Patients enrolled

Trial Details

Trial ID

NCT04460612

Start Date

May 26 2021

End Date

July 12 2022

Last Update

July 14 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Endocrine Associates Of Connecticut

Hamden, Connecticut, United States, 06517